The efficacy you expect
Milpro® is a broad-spectrum wormer containing milbemycin and praziquantel in palatable tablet form, which offers protection against parasitic worms in dogs and cats, including roundworm and tapeworm. It is also licensed for the prevention and treatment of Angiostrongylus vasorum in dogs.
Product Features & Benefits:
Broad-spectrum coverage against the most common parasitic worms of dogs and cats with a tried and trusted ingredient combination
Meat-flavoured film-coated tablets for palatability and ease of administration
Range of tablet and pack sizes for puppies, dogs, kittens and cats to provide flexible dispensing options
Tablets scored on both sides for easy dosing
Colour-coded packaging means it's easy to distinguish between items in the range
Awarded the ISFM 'Easy to Give' award
Approved for use in dogs >0.5kg and over 2 weeks of age
Approved for use in cats >0.5kg and over 6 weeks of age
Use medicines responsibly. www.noah.co.uk/responsible.
Further information is available on the SPC or on request from Virbac Ltd.
1. European registration file.
2. Wormers sensory study, Ipsos 2014.
Milbemycin belongs to the avermectin class of anthelmintics. Moxidectin and selamectin also belong to this group and the corresponding SPCs for the medicines should be consulted for guidance on concurrent use. For example, selamectin products can be used with milbemycin, but moxidectin containing products are not recommended to be used concurrently with milbemycin.
Real chicken liver flavour is used to improve compliance and help owners worm their pets.
For Milpro Puppy the weight range is 0.5kg to 10kg. With one tablet covering 0.5kg to 5kg. Two tablets are needed for puppies or small dogs weighing between 5 and 10kg.
Milpro Adult Dogs - 1 tablet for dogs weighing between 5 and 25kg.
Using Milpro Kittens and Small Cats - 0.5 - 1 kg = ½ tablet; >1 - 2 kg = 1 tablet
Using Milpro Adult Cat - 2 - 4 kg = ½ tablet; >4 - 8 kg = 1 tablet
Milpro is a generic hybrid and as such the trials carried out for the registration dossier are assessed for ethical purposes and only essential and critical studies are permitted. As milbemycin and praziquantel has been previously studied in the reference product for use in pregnancy a trial for Milpro was not performed. Therefore the SPC states - use during pregnancy and lactation only according to a benefit / risk assessment by the responsible veterinarian.